{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:10:52Z","timestamp":1790619052427,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["CNPq INCT 573747\/20083"],"award-info":[{"award-number":["CNPq INCT 573747\/20083"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PPSUS"},{"DOI":"10.13039\/501100004263","name":"FAPERGS","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004263","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12887-016-0772-x","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T05:35:07Z","timestamp":1484631307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants"],"prefix":"10.1186","volume":"17","author":[{"given":"Cristiane","family":"Kopacek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone Martins","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayara Jorgens","family":"Prado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Maria Dornelles","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Amorim","family":"Beltr\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poli Mara","family":"Spritzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"issue":"3","key":"772_CR1","first-page":"245","volume":"21","author":"PC White","year":"2000","unstructured":"White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev. 2000;21(3):245\u201391.","journal-title":"Endocr Rev"},{"issue":"9","key":"772_CR2","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.1210\/jc.2009-2631","volume":"95","author":"PW Speiser","year":"2010","unstructured":"Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(9):4133\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"772_CR3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1590\/S0004-27302004000500016","volume":"48","author":"TA Bachega","year":"2004","unstructured":"Bachega TA, Billerbeck AE, Parente EB, Lemos-Marini SH, Baptista MT, Mello MP, Guerra Jr G, Kuperman H, Setian N, Damiani D, Torres N, Castro M, Mendon\u00e7a BB. Multicentric study of Brazilian patients with 21-hydroxylase deficiency: a genotypephenotype correlation. Arq Bras Endocrinol Metabol. 2004;48(5):697\u2013704.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"9","key":"772_CR4","doi-asserted-by":"crossref","first-page":"4048","DOI":"10.1210\/jc.2002-020611","volume":"87","author":"Joint LWPES\/ESPE CAH Working Group","year":"2002","unstructured":"Joint LWPES\/ESPE CAH Working Group. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Paediatric Endocrinology. J Clin Endocrinol Metab. 2002;87(9):4048\u201353.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"772_CR5","first-page":"90","volume":"68","author":"PW Speiser","year":"2007","unstructured":"Speiser PW. Prenatal and neonatal diagnosis and treatment of congenital adrenal hyperplasia. Horm Res. 2007;68(5):90\u20132.","journal-title":"Horm Res"},{"issue":"6","key":"772_CR6","first-page":"866","volume":"81","author":"SY Pang","year":"1988","unstructured":"Pang SY, Wallace MA, Hofman L, Thuline HC, Dorche C, Lyon IC, Dobbins RH, Kling S, Fujieda K, Suwa S. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics. 1988;81(6):866\u201374.","journal-title":"Pediatrics"},{"issue":"1","key":"772_CR7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0022-3476(97)70321-4","volume":"130","author":"DB Allen","year":"1997","unstructured":"Allen DB, Hoffman GL, Fitzpatrick P, Laessig R, Maby S, Slyper A. Improved precision of newborn screening for congenital adrenal hyperplasia using weight-adjusted criteria for 17-hydroxyprogesterone levels. J Pediatr. 1997;130(1):128\u201333.","journal-title":"J Pediatr"},{"issue":"4","key":"772_CR8","doi-asserted-by":"crossref","first-page":"E68","DOI":"10.1542\/peds.108.4.e68","volume":"108","author":"A Nordenstr\u00f6m","year":"2001","unstructured":"Nordenstr\u00f6m A, Wedell A, Hagenfeldt L, Marcus C, Larsson A. Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics. 2001;108(4):E68.","journal-title":"Pediatrics"},{"issue":"12","key":"772_CR9","doi-asserted-by":"crossref","first-page":"5790","DOI":"10.1210\/jc.2002-021732","volume":"88","author":"B Olgem\u00f6ller","year":"2003","unstructured":"Olgem\u00f6ller B, Roscher AA, Liebl B, Fingerhut R. Screening for congenital adrenal hyperplasia: adjustment of 17-hydroxyprogesterone cut-off values to both age and birth weight markedly improves the predictive value. J Clin Endocrinol Metab. 2003;88(12):5790\u20134.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"772_CR10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1590\/S0004-27302011000800019","volume":"55","author":"G Hayashi","year":"2011","unstructured":"Hayashi G, Faure C, Brondi MF, Vallejos C, Soares D, Oliveira E, Brito VN, Mendonca BB, Bachega TA. Weight-adjusted neonatal 17OH-progesterone cutoff levels improve the efficiency of newborn screening for congenital adrenal hyperplasia. Arq Bras Endocrinol Metabol. 2011;55(8):632\u20137.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"1","key":"772_CR11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12887-015-0529-y","volume":"15","author":"A Tsuji","year":"2015","unstructured":"Tsuji A, Konishi K, Hasegawa S, Anazawa A, Onishi T, Ono M, Morio T, Kitagawa T, Kashimada K. Newborn screening for congenital adrenal hyperplasia in Tokyo, Japan from 1989 to 2013: a retrospective population-based study. BMC Pediatr. 2015;15(1):209.","journal-title":"BMC Pediatr"},{"issue":"2","key":"772_CR12","first-page":"88","volume":"67","author":"G Pauwels","year":"2012","unstructured":"Pauwels G, Allegaert NK, R\u00e9gal L, Meulemans A. Risk factors for elevated levels of 17-hydroxyprogesterone during neonatal intensive care unit admission. Acta Clin Belg. 2012;67(2):88\u201393.","journal-title":"Acta Clin Belg"},{"issue":"5","key":"772_CR13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1203\/01.PDR.0000142733.50918.6E","volume":"56","author":"F Gatelais","year":"2004","unstructured":"Gatelais F, Berthelot J, Beringue F, Descamps P, Bonneau D, Limal JM, Coutant R. Effect of single and multiple courses of prenatal corticosteroids on 17 hydroxyprogesterone levels: implication for neonatal screening of congenital adrenal hyperplasia. Pediatr Res. 2004;56(5):701\u20135.","journal-title":"Pediatr Res"},{"issue":"5","key":"772_CR14","doi-asserted-by":"publisher","first-page":"e1261","DOI":"10.1542\/peds.2012-1219","volume":"130","author":"K Sarafoglou","year":"2012","unstructured":"Sarafoglou K, Banks K, Gaviglio A, Hietala A, McCann M, Thomas W. Comparison of one-tier and two-tier newborn screening metrics for congenital adrenal hyperplasia. Pediatrics. 2012;130(5):e1261\u20138. doi: 10.1542\/peds.2012-1219 . Epub 2012 Oct 15.","journal-title":"Pediatrics"},{"issue":"2","key":"772_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000156115","volume":"12","author":"BK Yoo","year":"2009","unstructured":"Yoo BK, Grosse SD. The cost effectiveness of screening newborns for congenital adrenal hyperplasia. Public Health Genomics. 2009;12(2):67\u201372. doi: 10.1159\/000156115 . Epub 2008 Sep.","journal-title":"Public Health Genomics"},{"issue":"4","key":"772_CR16","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1590\/S0104-42302012000400017","volume":"58","author":"CB Barra","year":"2012","unstructured":"Barra CB, Silva IN, Pezzuti IL, Janu\u00e1rio JN. Neonatal screening for congenital adrenal hyperplasia. Rev Assoc Med Bras. 2012;58(4):459\u201364.","journal-title":"Rev Assoc Med Bras"},{"issue":"3","key":"772_CR17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jped.2013.09.007","volume":"90","author":"IL Pezzuti","year":"2014","unstructured":"Pezzuti IL, Barra CB, Mantovani RM, Janu\u00e1rio JN, Silva IN. A three-year follow-up of congenital adrenal hyperplasia newborn screening. J Pediatr. 2014;90(3):300\u2013407.","journal-title":"J Pediatr"},{"issue":"5","key":"772_CR18","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1515\/JPEM.2008.21.5.455","volume":"21","author":"EL Silveira","year":"2008","unstructured":"Silveira EL, dos Santos EP, Bachega TA, van der Linden Nader I, Gross JL, Elnecave RH. The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred\u2014an estimate based on a public neonatal screening program in the state of Goi\u00e1s. J Pediatr Endocrinol Metab. 2008;21(5):455\u201360.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"772_CR19","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1590\/0004-2730000003310","volume":"58","author":"ML Nascimento","year":"2014","unstructured":"Nascimento ML, Cristiano AN, Campos T, Ohira M, Cechinel E, Simoni G, Lee J, Linhares RM, Silva PC. Ten-year evaluation of a Neonatal Screening Program for congenital adrenal hyperplasia. Arq Bras Endocrinol Metabol. 2014;58(7):765\u201371.","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"772_CR20","unstructured":"Triagem neonatal: hiperplasia adrenal cong\u00eanita\/Minist\u00e9rio da Sa\u00fade, Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade, Departamento de Aten\u00e7\u00e3o Especializada e Tem\u00e1tica.\u2013Bras\u00edlia: Minist\u00e9rio da Sa\u00fade, 2015. 44 p. : il. Editora MS\u2013OS 2015\/0241 ISBN 978-85-334-2262-9. Printed in Brazil."},{"key":"772_CR21","unstructured":"IBGE. Censo Demogr\u00e1fico 2010. Available at: http:\/\/www.censo2010.ibge.gov.br . Accessed 11 Mar 2016."},{"key":"772_CR22","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-45-5-1003","volume":"45","author":"S Pang","year":"1977","unstructured":"Pang S, Hotchkiss J, Drash AL, Levine LS, New MI. Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab. 1977;45:1003\u2013100.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"772_CR23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0929-693X(99)80202-4","volume":"6","author":"M Cartigny-Maciejewski","year":"1999","unstructured":"Cartigny-Maciejewski M, Guilley N, Vanderbecken S, Gond\u00e9 S, Stuckens C, Pont\u00e9 C, Weill J, Farriaux JP, Paux E. Neonatal screening of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Lille experience 1980\u20131996. Arch Pediatr. 1999;6(2):151\u20138.","journal-title":"Arch Pediatr"},{"issue":"9","key":"772_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nrendo.2009.148","volume":"5","author":"PC White","year":"2009","unstructured":"White PC. Neonatal screening for congenital adrenal hyperplasia. Nat Rev Endocrinol. 2009;5(9):490\u20138. doi: 10.1038\/nrendo.2009.148 .","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"772_CR25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1373\/clinchem.2003.027193","volume":"50","author":"JM Lacey","year":"2004","unstructured":"Lacey JM, Minutti CZ, Magera MJ, Tauscher AL, Casetta B, McCann M, Lymp J, Hahn SH, Rinaldo P, Matern D. Improved specificity of newborn screening for congenital adrenal hyperplasia by second-tier steroid profiling using tandem mass spectrometry. Clin Chem. 2004;50(3):621\u20135.","journal-title":"Clin Chem"},{"key":"772_CR26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1203\/PDR.0b013e3181aa3777","volume":"66","author":"E Schwarz","year":"2009","unstructured":"Schwarz E, Liu A, Randall H, Haslip C, Keune F, Murray M, et al. Use of steroid profiling by UPLC-MS\/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience. Pediatr Res. 2009;66:230\u20135.","journal-title":"Pediatr Res"},{"issue":"1","key":"772_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1297\/cpe.25.1","volume":"25","author":"T Tajima","year":"2016","unstructured":"Tajima T, Fukushi M. Neonatal mass screening for 21-hydroxylase deficiency. Clin Pediatr Endocrinol. 2016;25(1):1\u20138. doi: 10.1297\/cpe.25.1 . Epub 2016 Jan 30.","journal-title":"Clin Pediatr Endocrinol"},{"key":"772_CR28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1001\/archpediatrics.2011.774","volume":"166","author":"B Coulm","year":"2012","unstructured":"Coulm B, Coste J, Tardy V, Ecosse E, Roussey M, Morel Y, et al. DHCSF Study Group Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003. Arch Pediatr Adolesc Med. 2012;166:113\u201320.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"7","key":"772_CR29","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1001\/archpedi.154.7.714","volume":"154","author":"C Kwon","year":"2000","unstructured":"Kwon C, Farrell PM. The Magnitude and Challenge of False-Positive Newborn Screening Test Results. Arch Pediatr Adolesc Med. 2000;154(7):714\u20138. doi: 10.1001\/archpedi.154.7.714 .","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"772_CR30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamapediatrics.2013.5321","volume":"168","author":"S Gidlof","year":"2014","unstructured":"Gidlof S, Wedell A, Guthenberg C, von Dobeln U, Nordenstrom A. Nationwide Neonatal Screening for Congenital Adrenal Hyperplasia in Sweden: A 26-Year Longitudinal Prospective Population-Based Study. JAMA Pediatr. 2014;168(6):567\u201374.","journal-title":"JAMA Pediatr"},{"issue":"4","key":"772_CR31","first-page":"203","volume":"19","author":"CA Alves","year":"2006","unstructured":"Alves CA, Junior VB, Toralles MB. Neonatal screening for congenital adrenal hyperplasia: considerations regarding the transient rise of the 17-hydroxyprogesterone. Braz J Promot (RBPS). 2006;19(4):203\u20138.","journal-title":"Braz J Promot (RBPS)"},{"key":"772_CR32","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0378-3782(97)00037-6","volume":"49","author":"S Nomura","year":"1997","unstructured":"Nomura S. Immature adrenal steroidogenesis in preterm infants. Early Hum Dev. 1997;49:225\u201333.","journal-title":"Early Hum Dev"},{"issue":"3","key":"772_CR33","first-page":"235","volume":"38","author":"JE Lee","year":"2008","unstructured":"Lee JE, Moon Y, Lee MH, Jun YH, Oh KI, Choi JW. Corrected 17-alpha hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants. Ann Clin Lab Sci. 2008;38(3):235\u201340.","journal-title":"Ann Clin Lab Sci"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-016-0772-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T11:02:24Z","timestamp":1526641344000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-016-0772-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["772"],"URL":"https:\/\/doi.org\/10.1186\/s12887-016-0772-x","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,17]]},"article-number":"22"}}